News Sentiment

BAFNAPH sentiment intelligence

Bafna Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 54 Balanced news tone 11 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 204.61 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 11

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-5.5% over one week, +23.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Bafna Pharmaceuticals Files SEBI Demat Compliance Certificate for June Quarter

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -5.5% Price reacting lower
Trend fit Trend active 23.7% over four weeks
Fair value 99.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 9
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 11
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
scanx.trade 4
Business Standard 2
TipRanks 1
ad-hoc-news.de 1
CNBC TV18 1
BW Healthcare 1
The Economic Times 1

Event Lens

What the news is about

Classified themes
Market update 6
Earnings 3
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-11 of 11